首页> 外国专利> INHIBITOR MOLECULES OF PROTEIN SYNTHESIS OF HEPATITIS C VIRUS AND METHOD FOR SCREENING THESE INHIBITORY MOLECULES

INHIBITOR MOLECULES OF PROTEIN SYNTHESIS OF HEPATITIS C VIRUS AND METHOD FOR SCREENING THESE INHIBITORY MOLECULES

机译:丙型肝炎病毒蛋白合成的抑制剂分子和筛选这些抑制剂分子的方法

摘要

In vitro method of screening for compounds (A) that inhibit formation of a complex between the p110 subunit of the eukaryotic translation initiation factor eIF3 and region II of the IRES (internal ribosome entry site) of hepatitis C virus (HCV). In vitro method of screening for compounds (A) that inhibit formation of a complex between the p110 subunit of the eukaryotic translation initiation factor eIF3 and region II of the IRES (internal ribosome entry site) of hepatitis C virus (HCV) comprises: (a) incubating p110 (814 amino acid sequence, given in the specification), region II (80 base pair sequence, given in the specification), or a fragment containing at least 10 consecutive nucleotides, and test compound; (b) detecting any formation of a p110/region II complex; and (c) selecting those compounds that inhibit formation of this complex.
机译:筛选抑制真核翻译起始因子eIF3的p110亚基与丙型肝炎病毒(HCV)的IRES区域II(内部核糖体进入位点)之间形成复合物的化合物(A)的体外方法。筛选抑制真核翻译起始因子eIF3的p110亚基与丙型肝炎病毒(HCV)的IRES区域II(内部核糖体进入位点)之间形成复合物的化合物(A)的体外方法包括:(a )孵育p110(说明书中给出的814个氨基酸序列),II区(说明书中给出的80个碱基对序列)或包含至少10个连续核苷酸的片段以及测试化合物; (b)检测p110 / II区复合物的任何形成; (c)选择抑制该复合物形成的那些化合物。

著录项

  • 公开/公告号FR2848572B1

    专利类型

  • 公开/公告日2005-12-09

    原文格式PDF

  • 申请/专利权人 UNIVERSITE JOSEPH FOURIER;

    申请/专利号FR20020015718

  • 发明设计人 BALAKIREVA LARISSA;

    申请日2002-12-12

  • 分类号C12Q1/68;G01N33/68;G01N33/60;A61K31/7105;A61P31/14;A61P35/00;

  • 国家 FR

  • 入库时间 2022-08-21 21:17:35

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号